IS2787B - Módafíníllyfjasamsetningar með breytta losun - Google Patents
Módafíníllyfjasamsetningar með breytta losunInfo
- Publication number
- IS2787B IS2787B IS8327A IS8327A IS2787B IS 2787 B IS2787 B IS 2787B IS 8327 A IS8327 A IS 8327A IS 8327 A IS8327 A IS 8327A IS 2787 B IS2787 B IS 2787B
- Authority
- IS
- Iceland
- Prior art keywords
- modafinil
- release formulations
- modified release
- modified
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50402803P | 2003-09-18 | 2003-09-18 | |
US10/944,528 US8153159B2 (en) | 2003-09-18 | 2004-09-17 | Modafinil modified release pharmaceutical compositions |
PCT/US2004/030815 WO2005027890A1 (en) | 2003-09-18 | 2004-09-20 | Modafinil modified release pharmaceutical compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
IS8327A IS8327A (is) | 2006-02-23 |
IS2787B true IS2787B (is) | 2012-06-15 |
Family
ID=34381093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS8327A IS2787B (is) | 2003-09-18 | 2006-02-23 | Módafíníllyfjasamsetningar með breytta losun |
Country Status (21)
Country | Link |
---|---|
US (1) | US8153159B2 (is) |
EP (1) | EP1670447B1 (is) |
JP (1) | JP5138932B2 (is) |
KR (1) | KR20060117910A (is) |
AR (1) | AR046410A1 (is) |
AT (1) | ATE448780T1 (is) |
AU (1) | AU2004274017B2 (is) |
BR (1) | BRPI0414299A (is) |
CA (1) | CA2536666C (is) |
DE (1) | DE602004024220D1 (is) |
EA (1) | EA011400B1 (is) |
ES (1) | ES2336215T3 (is) |
HK (1) | HK1089697A1 (is) |
IL (1) | IL173738A (is) |
IS (1) | IS2787B (is) |
MX (1) | MXPA06003125A (is) |
MY (1) | MY144755A (is) |
NO (1) | NO20060964L (is) |
NZ (1) | NZ545573A (is) |
TW (1) | TWI344840B (is) |
WO (1) | WO2005027890A1 (is) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL205109B1 (pl) * | 1998-11-02 | 2010-03-31 | Elan Pharma Int Ltd | Wielocząstkowa kompozycja metylofenidatu o modyfikowanym uwalnianiu i jej zastosowanie |
WO2005117585A1 (en) * | 2004-05-28 | 2005-12-15 | Transform Pharmaceuticals, Inc. | Mixed co-crystals and pharmaceutical compositions comprising the same |
US20060121112A1 (en) * | 2004-12-08 | 2006-06-08 | Elan Corporation, Plc | Topiramate pharmaceutical composition |
US20100136106A1 (en) * | 2005-06-08 | 2010-06-03 | Gary Liversidge | Modified Release Famciclovir Compositions |
WO2007095523A2 (en) | 2006-02-13 | 2007-08-23 | Vanda Pharmaceuticals, Inc. | Stable dosage formulations of imidazolylalkyl-pyridines |
MX2009000391A (es) * | 2006-07-12 | 2009-06-30 | Elan Pharma Int Ltd | Formulación de modafinilo en forma de nano-partículas. |
DE102006035549A1 (de) * | 2006-07-27 | 2008-01-31 | Evonik Röhm Gmbh | Arzneiform mit mindestens zweischichtiger Trennschicht |
US20090082461A1 (en) * | 2007-09-25 | 2009-03-26 | Protia, Llc | Deuterium-enriched modafinil |
JP5250285B2 (ja) * | 2008-03-26 | 2013-07-31 | 富士フイルム株式会社 | 経口物用被覆材、可食性容器およびそれらを用いた経口物 |
WO2010012407A1 (en) * | 2008-07-29 | 2010-02-04 | Ashland Licensing And Intellectual Property Llc. | Modified additives for suppressing dust formation |
EP2591773A4 (en) * | 2010-07-06 | 2014-11-26 | Navipharm Co Ltd | TEMPORARY RELEASED PHARMACEUTICAL COMPOSITION WITH DAPOXIN FOR ORAL ADMINISTRATION |
US8999393B1 (en) * | 2013-01-09 | 2015-04-07 | Edgemont Pharmaceuticals Llc | Sustained release formulations of lorazepam |
PL3137060T5 (pl) | 2014-05-01 | 2024-04-08 | Sun Pharmaceutical Industries Ltd | Kompozycje zawiesinowe o przedłużonym uwalnianiu |
EP3355865A1 (en) | 2015-09-29 | 2018-08-08 | Acorda Therapeutics, Inc. | Sustained release compositions of 4-aminopyridine |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5534263A (en) * | 1995-02-24 | 1996-07-09 | Alza Corporation | Active agent dosage form comprising a matrix and at least two insoluble bands |
US6346548B1 (en) * | 1999-08-16 | 2002-02-12 | Cephalon, Inc. | Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
US6627223B2 (en) * | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
US6458384B2 (en) * | 2000-02-23 | 2002-10-01 | Impetus Ag | Pharmaceutical with predetermined activity profile |
US6492396B2 (en) | 2000-05-16 | 2002-12-10 | Cephalon, Inc. | Substituted thioacetamides |
US6489363B2 (en) * | 2000-10-11 | 2002-12-03 | Cephalon, Inc. | Pharmaceutical solutions of modafinil compounds |
US6344215B1 (en) * | 2000-10-27 | 2002-02-05 | Eurand America, Inc. | Methylphenidate modified release formulations |
US7141555B2 (en) | 2000-12-19 | 2006-11-28 | Cephalon, Inc. | Modafinil compound and cyclodextrin mixtures |
IL158959A (en) | 2001-05-25 | 2010-06-30 | Cephalon Inc | Solid pharmaceutical formulations comprising modafinil |
GB0117618D0 (en) | 2001-07-19 | 2001-09-12 | Phoqus Ltd | Pharmaceutical dosage form |
US7229644B2 (en) * | 2002-05-23 | 2007-06-12 | Cephalon, Inc. | Pharmaceutical formulations of modafinil |
US20040116532A1 (en) | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
-
2004
- 2004-09-17 AR ARP040103336A patent/AR046410A1/es unknown
- 2004-09-17 US US10/944,528 patent/US8153159B2/en not_active Expired - Fee Related
- 2004-09-20 MY MYPI20043844A patent/MY144755A/en unknown
- 2004-09-20 KR KR1020067005361A patent/KR20060117910A/ko not_active Application Discontinuation
- 2004-09-20 JP JP2006527123A patent/JP5138932B2/ja not_active Expired - Fee Related
- 2004-09-20 ES ES04788862T patent/ES2336215T3/es active Active
- 2004-09-20 AU AU2004274017A patent/AU2004274017B2/en not_active Ceased
- 2004-09-20 AT AT04788862T patent/ATE448780T1/de not_active IP Right Cessation
- 2004-09-20 TW TW093128394A patent/TWI344840B/zh not_active IP Right Cessation
- 2004-09-20 WO PCT/US2004/030815 patent/WO2005027890A1/en active Search and Examination
- 2004-09-20 BR BRPI0414299-3A patent/BRPI0414299A/pt not_active IP Right Cessation
- 2004-09-20 NZ NZ545573A patent/NZ545573A/en unknown
- 2004-09-20 MX MXPA06003125A patent/MXPA06003125A/es active IP Right Grant
- 2004-09-20 EA EA200600590A patent/EA011400B1/ru not_active IP Right Cessation
- 2004-09-20 CA CA2536666A patent/CA2536666C/en not_active Expired - Fee Related
- 2004-09-20 DE DE602004024220T patent/DE602004024220D1/de active Active
- 2004-09-20 EP EP04788862A patent/EP1670447B1/en active Active
-
2006
- 2006-02-14 IL IL173738A patent/IL173738A/en not_active IP Right Cessation
- 2006-02-23 IS IS8327A patent/IS2787B/is unknown
- 2006-02-28 NO NO20060964A patent/NO20060964L/no not_active Application Discontinuation
- 2006-10-23 HK HK06111632.5A patent/HK1089697A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2007518696A (ja) | 2007-07-12 |
EP1670447A1 (en) | 2006-06-21 |
CA2536666C (en) | 2012-06-19 |
DE602004024220D1 (de) | 2009-12-31 |
EA200600590A1 (ru) | 2006-08-25 |
JP5138932B2 (ja) | 2013-02-06 |
AU2004274017B2 (en) | 2010-07-08 |
BRPI0414299A (pt) | 2006-11-14 |
US8153159B2 (en) | 2012-04-10 |
IL173738A0 (en) | 2006-07-05 |
CA2536666A1 (en) | 2005-03-31 |
NZ545573A (en) | 2010-02-26 |
US20050095294A1 (en) | 2005-05-05 |
HK1089697A1 (en) | 2006-12-08 |
MXPA06003125A (es) | 2006-06-20 |
WO2005027890A1 (en) | 2005-03-31 |
EA011400B1 (ru) | 2009-02-27 |
ES2336215T3 (es) | 2010-04-09 |
IS8327A (is) | 2006-02-23 |
ATE448780T1 (de) | 2009-12-15 |
AU2004274017A1 (en) | 2005-03-31 |
IL173738A (en) | 2012-07-31 |
TWI344840B (en) | 2011-07-11 |
TW200520748A (en) | 2005-07-01 |
NO20060964L (no) | 2006-04-18 |
EP1670447B1 (en) | 2009-11-18 |
KR20060117910A (ko) | 2006-11-17 |
AR046410A1 (es) | 2005-12-07 |
MY144755A (en) | 2011-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS2787B (is) | Módafíníllyfjasamsetningar með breytta losun | |
IS8309A (is) | Lyfjablöndur | |
NO20052635D0 (no) | Kontrollert frigivelsesdepot formuleringer | |
NO20050132D0 (no) | Vaksinesammensetning | |
DK1812025T3 (da) | Stabiliserede bakteriofagformuleringer | |
DE602004008136D1 (de) | Härtbare Zusammensetzung | |
FR2862654B1 (fr) | Composition amylacee filmogene | |
NO20052239D0 (no) | Fast preparat | |
FI6928U1 (fi) | Peliautomaatti | |
MX266708B (es) | Formulaciones de microparticulas de pantoprazol. | |
DK1670440T3 (da) | HRT formuleringer | |
IS7715A (is) | Nýjar lyfjasamsetningar úr módafíníl | |
DE602004018602D1 (de) | Mikrospiegel | |
IS7582A (is) | Hraðlosandi lyfjablanda | |
IS8325A (is) | Bóluefni | |
NO20060375L (no) | Famasoytisk preparat | |
IS8011A (is) | Venlafaxín samsetningar með tafinni losun | |
DE60333672D1 (de) | Sprühbare ölartige formulierungen | |
NO20044337L (no) | Faststoff-dispergeringspreparat | |
DE502004006272D1 (de) | Schutzschalter | |
DE50307407D1 (de) | Strömungsbremse | |
ATE365529T1 (de) | Schweisshemmende zusammensetzungen | |
ZA200603030B (en) | Modafinil modified release pharmaceutical compositions | |
DE602004016637D1 (de) | Abferkelstation | |
ITMI20030198A1 (it) | Composizioni espandenti |